Ken Griffin’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Ken Griffin’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-140,003	Closed	-$1.4M	–	15956
2022 Q3	$1.4M	Sell	140,003 -60,077	-30%	-$596K	﹤0.01%	6298
2022 Q2	$1.98M	Sell	200,080 -353,188	-64%	-$3.48M	﹤0.01%	5570
2022 Q1	$5.43M	Sell	553,268 -4	-0%	-$39	﹤0.01%	4013
2021 Q4	$5.39M	Sell	553,272 -1,143	-0.2%	-$11.2K	﹤0.01%	4159
2021 Q3	$5.45M	Buy	554,415 +164	+0%	+$1.6K	﹤0.01%	4146
2021 Q2	$5.41M	Buy	554,251 +4,251	+0.8%	+$41.9K	﹤0.01%	4263
2021 Q1	$5.47M	Buy	+550,000	New	+$5.61M	﹤0.01%	4057

Ken Griffin's FLAC Position: Q4 2022 in Review

Ken Griffin sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 140,003 shares — an estimated $1.4M sold.

Ken Griffin first reported a position in FLAC in Q1 2021 and held it in 7 quarters. The position peaked at $5.47M in Q1 2021. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Ken Griffin reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Ken Griffin sold 140,003 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $1.4M.
Ken Griffin first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
Ken Griffin's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $5.47M in Q1 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.